Evette J. Ludman, PhD

Articles by Evette J. Ludman, PhD

Population Targeting and Durability of Multimorbidity Collaborative Care Management

ByElizabeth H.B. Lin, MD, MPH,Michael Von Korff, ScD,Do Peterson, MS,Evette J. Ludman, PhD,Paul Ciechanowski, MD, MPH,Wayne Katon, MD

November 19th 2014

Benefits of a patient-centered multimorbidity care management program occurred early, and were evident only among patients with depression and unfavorable medical control of diabetes and heart disease.

Does Telephone Care Management Help Medicaid Beneficiaries With Depression?

BySue E. Kim, PhD, MPH,Allen J. LeBlanc, PhD,Charles Michalopoulos, PhD,Francisca Azocar, PhD,Evette J. Ludman, PhD,David M. Butler, MA,Greg E. Simon, MD, MPH

October 17th 2011

Telephone care management increased mental health service use for Medicaid beneficiaries with depression but did not reduce depression severity. More intensive services may be needed.

Diabetes Complications Severity Index and Risk of Mortality, Hospitalization, and Healthcare Utilization

ByBessie Ann Young, MD, MPH,Elizabeth Lin, MD, MPH,Michael Von Korff, ScD,Greg Simon, MD, MPH,Paul Ciechanowski, MD, MPH,Evette J. Ludman, PhD,Siobhan Everson-Stewart, BA,Leslie Kinder, PhD,Malia Oliver, BA,Edward J. Boyko, MD, MPH,Wayne J. Katon, MD

January 15th 2008

Latest Updated Articles

Population Targeting and Durability of Multimorbidity Collaborative Care Management
November 19th 2014
Diabetes Complications Severity Index and Risk of Mortality, Hospitalization, and Healthcare Utilization
January 15th 2008
Does Telephone Care Management Help Medicaid Beneficiaries With Depression?
October 17th 2011

Evette J. Ludman, PhD

Articles by Evette J. Ludman, PhD

Population Targeting and Durability of Multimorbidity Collaborative Care Management

Does Telephone Care Management Help Medicaid Beneficiaries With Depression?

Diabetes Complications Severity Index and Risk of Mortality, Hospitalization, and Healthcare Utilization

Latest Updated Articles

Trending on AJMC

FDA Panel Backs 6 Peptides for Compounding

Oncology Leaders Call for Greater Collaboration to Advance Precision Medicine, Innovative Cancer Care

Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%

FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies

Study Shows Potential for Low-Dose CAR T, With Implications for Increased Access